Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Neurofibrosarcoma 1Colorectal Neoplasms 1

Interventions

pembrolizumab 2Nivolumab 2romidepsin 1metarrestin 1fludarabine phosphate 1fludarabine 1brostallicin 1Trabectedin 1Specimen Handling 1Mesna 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Imatinib Mesylate 1HhAntag691 1Dasatinib 1Cyclophosphamide 1CTLA-4 Antigen 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibrosarcoma × metarrestin × Gastrointestinal × Clear all
NCT04222413 2026-04-24

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
116 enrolled
GastrointestinalSarcoma

Pancreatic Neoplasms, Colorectal Neoplasms, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡